Purpose: To determine the corneal biomechanical properties in eyes with glaucoma using a non-contact Scheimpflug-based tonometer. Methods: Corneal biomechanical responses were examined using a non-contact Scheimpflug-based tonometer. The tonometer parameters of the normal control group (n = 75) were compared with those of the glaucoma group (n = 136), including an analysis of glaucoma subgroups categorized by visual field loss. Results: After adjusting for potential confounding factors, including the intraocular pressure (IOP), central corneal thickness (CCT), age and axial length, the deformation amplitude was smaller in the glaucoma group (1.09 AE 0.02 mm) than in the normal control group (1.12 AE 0.02 mm; p value = 0.031). The deformation amplitude and the deflection amplitude of the severe glaucoma group (1.12 AE 0.02 mm and 0.92 AE 0.01 mm) were significantly greater than that of the early glaucoma group (1.07 AE 0.01 mm and 0.88 AE 0.11 mm, p = 0.006 and p = 0.031), whereas that of the moderate glaucoma group (1.09 AE 0.02 mm and 0.90 AE 0.02 mm) was greater than that of the early glaucoma group, but this difference was not statistically significant. The deformation amplitude showed a negative correlation with the CCT in the normal control group (r = À0.235), with a weaker negative relationship observed in the early glaucoma group (r = À0.099). However, in the moderate and severe glaucoma groups, the deformation amplitude showed a positive relationship with the CCT, showing an inverse relationship. The duration and number of antiglaucomatous eyedrops used had negative correlations with the CCT in eyes with moderate and severe glaucoma. Conclusion: Overall, the glaucoma group showed significantly less deformable corneas than did the normal controls, even after adjusting for the IOP, CCT, age and axial length. However, there were also differences according to the severity of glaucoma, where the corneal deformation amplitude was greater in the severe glaucoma group compared to the early glaucoma group. The combined effects of stiffening due to glaucoma and increased viscoelastic properties caused by the chronic use of antiglaucomatous eyedrops may have resulted in the present findings.
Introduction
The relationship between glaucoma and the corneal biomechanical properties has gained increasing attention. Understanding the biomechanical properties of the cornea may lead to a more accurate diagnosis and better management of glaucoma (Liu & Roberts 2005; Congdon et al. 2006; Medeiros & Weinreb 2006) . Biomechanical properties may influence the cornea's response to applanation, which may affect the IOP measurements (Liu & Roberts 2005; Medeiros & Weinreb 2006; Costin et al. 2014; Shin et al. 2015) . Furthermore, it has been suggested that the corneal biomechanical properties reflect structural vulnerabilities related to the development and progression of glaucoma (Congdon et al. 2006; Wells et al. 2008; Medeiros et al. 2013) . Thus, many studies have evaluated potential alterations in the corneal biomechanical properties in glaucoma patients (Mangouritsas et al. 2009; Mansouri et al. 2012; Morita et al. 2012; Yazgan et al. 2014; Shin et al. 2015) .
The recent introduction of the Corvis ST (Oculus, Wetzlar, Germany) has enabled more accurate assessments of the corneal deformation process and allows in vivo observations of the biomechanical properties of the cornea. The instrument is based on ultra-highspeed Scheimpflug technology and measures the IOP, optical pachymetry and corneal biomechanical properties in vivo. Prior to the introduction of this instrument, only one instrument, the Ocular Response Analyzer (ORA; AMETEK Inc. and Reichert Inc., Depew, NY, USA), was available clinically that provided in vivo measurements of the corneal biomechanical responses. Both the ORA and Corvis ST obtain information about the corneal biomechanical properties by measuring the corneal deformation in response to an air impulse (Tejwani et al. 2014) . However, the ORA uses an electro-optical infrared system to calculate values, such as corneal hysteresis and the corneal resistance factor, using differential tonometry. However, these parameters do not provide information on specific changes in the corneal elastic properties, such as how stiff or soft the cornea is, but rather on the rate-dependent viscoelastic response (Glass et al. 2008; Huseynova et al. 2014) .
Studies have suggested that the Corvis ST can enable the identification of changes in the cornea's elastic properties ). Thus, it is possible that the Corvis ST may better reflect the corneal biomechanical changes in glaucomatous eyes because many studies have reported increased stiffness of ocular structures in glaucoma patients (Hernandez et al. 1990; Girard et al. 2011) . The purpose of this study was to examine and compare the corneal biomechanical properties between normal control eyes and eyes with glaucoma using the Corvis ST and to compare the values according to the severity of glaucoma, as defined by visual field damage.
Materials and Methods
In total, 211 patients were included in this retrospective observational study. The subjects included 136 glaucoma patients and 75 normal controls who visited the Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, in May 2014. The study followed the tenets of the Declaration of Helsinki for biomedical research and was approved by the Seoul St. Mary's Hospital Institutional Review Board.
The inclusion criteria for the study were less than three dioptres of cylinder correction and the presence of a normal anterior chamber and an open angle. Glaucoma was defined as the presence of a normal anterior chamber and an open angle on slit-lamp and gonioscopic examinations, a glaucomatous optic disc (diffuse or focal thinning of the neuroretinal rim) and an abnormal visual field consistent with glaucoma. These findings were confirmed by at least two reliable visual field examinations with a fixation loss <20%, a false-positive error <15% and a false-negative error <15%. The normal control group included patients who had an IOP of <22 mmHg with no history of an increased IOP, no history of using antiglaucomatous eyedrops, a non-glaucomatous optic nerve head and no visible retinal nerve fiber layer (RNFL) defect, as confirmed by two glaucoma experts (HLP and CKP). The exclusion criteria were a history of any previous or current corneal disease, a history of ocular trauma or surgery, or previous refractive laser treatment. When both eyes were eligible for the study, one eye was randomly included in the analysis.
Each participant underwent a complete ophthalmological examination which comprises of a detailed review of the ocular and medical histories including the number of topical medications for glaucoma, a best-corrected visual acuity (BCVA) evaluation, dilated stereoscopic optic nerve head examination, stereoscopic optic disc photography, red-free retinal nerve fibre layer photography (VX-10; Kowa Optimed, Tokyo, Japan), ultrasound pachymetry (Tomey Corporation, Nagoya, Japan) to measure the CCT, measurement of the corneal curvature using an autorefractor (RK-5, Canon, Tokyo, Japan), axial length measurement and achromatic automated perimetry using the 24-2 Swedish Interactive Threshold Algorithm (Humphrey Visual Field Analyzer; Carl Zeiss Meditec, Inc., Dublin, CA, USA). All subjects underwent IOP measurements with Goldmann applanation tonometry and the Corvis ST in random order. For each tonometer, the average of three measurements, with a 3-to 5-min interval between measurements, was used for the analysis, and there was a 30-min interval between the evaluations performed using the different tonometers.
The glaucoma group was categorized into three subgroups on the basis of the mean deviation (MD) of the visual field tests according to the modified Hodapp-Anderson-Parrish grading scale (Budenz et al. 2002) as follows: early glaucoma, MD greater than or equal to À6 dB; moderate glaucoma, MD between À6 and À12 dB; and severe glaucoma, MD less than or equal to À12 dB.
Corvis ST measurements
The Corvis ST (software ver. 102R1092; Oculus, Wetzlar, Germany) was used to obtain the measurements of the IOP and corneal biomechanical properties. When using this device, once the patient's cornea is centred appropriately, the device automatically emits an air impulse from a distance of 11 mm. An ultra-high-speed Scheimpflug camera records the corneal deformation process in response to the air impulse. The camera takes 140 digital frames with a resolution of 640 9 480 pixels in 30 ms with an 8.5 mm horizontal coverage of the central cornea. The recording starts with the cornea in the natural convex shape, at which time the CCT is measured. As the air impulse is emitted, the cornea moves inwards through applanation 1 (A1) or flattening of the cornea, into a concavity phase until it reaches the highest concavity (HC). Then, the cornea gradually returns to its natural shape, passing through a second applanation 2 (A2). The IOP is measured based on the time to A1. The Corvis ST parameters are listed in Table 1 . The deformation amplitude, which is the amount of corneal displacement at HC, is made up from the deflection amplitude, which is the pure corneal component, and the whole eye movement, which is the orbital component (Vellara et al. 2015; Matalia et al. 2016) . The deflection amplitude and the whole eye movement were retrospectively calculated using external analysis of the Corvis ST data.
Statistical analyses
To determine the significance of differences between the groups, an independent t-test was used for continuous variables and a chi-square test was used for categorical variables. A one-way analysis of variance and Scheff e's multiple comparison were used to compare the data among the groups. Possible effects of potential confounding variables including the age, axial length, IOP measured by the Corvis ST and the CCT measured by the Corvis ST were controlled by analyses of covariance (ANCOVA). The comparison of two regression lines was performed by comparing the slopes of the two lines (Kleinbaum & Kupper 1978; Park et al. 2015) . The SPSS software (ver. 18.0.0 for Windows; SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. Values of p < 0.05 were considered to indicate statistical significance.
Results
Of the 217 patients who met the inclusion criteria, six (2.8%) patients had unreliable Corvis ST measurements; thus, the study was based on a total of 211 patients (75 normal controls and 136 glaucoma patients). Among the patients in the glaucoma group, 53 had early visual field loss, 44 had moderate visual field loss and 39 had severe visual field loss. The age, refraction, keratometry, axial length and CCT were similar among the non-glaucoma group and the early, moderate and severe glaucoma groups. There were significant differences in the IOP (p = 0.019) and in the number and duration of antiglaucomatous medications used among the groups (p < 0.001 and p < 0.001, respectively; Table 2 ). Twenty-two eyes (41.5%), 27 eyes (61.4%) and 33 eyes (84.6%) were being treated with prostaglandin analogues in the early, moderate and severe glaucoma groups, respectively (p = 0.002). Table 3 shows the unadjusted Corvis ST parameters in the normal controls and glaucoma groups. The glaucoma group (1.06 AE 0.13 mm) showed less deformation amplitude compared to the normal control group (1.11 AE 0.10 mm, p = 0.002). The early glaucoma group showed significantly smaller deformation amplitude (1.03 AE 0.12 mm) compared to the severe glaucoma group (1.12 AE 0.14 mm, p < 0.001). The deflection amplitude did not differ between the normal control group (0.90 AE 0.10 mm) and the glaucoma group (0.89 AE 0.13 mm, p = 0.618). However, the defection amplitude of the severe glaucoma group (0.93 AE 0.15 mm) was statistically significantly higher than the early glaucoma group (0.85 AE 0.13 mm, p = 0.005). In addition, the whole eye movement was statistically significantly smaller in the glaucoma group (0.32 AE 0.09 mm) compared to the normal control group (0.36 AE 0.08 mm, p = 0.037). Table 4 shows the Corvis ST parameters after adjusting for the patient age, axial length, CCT and IOP. Overall, the glaucoma group showed a significantly smaller deformation amplitude than did the normal control group (p = 0.031). The deformation amplitude was significantly smaller in the early glaucoma group than in the severe glaucoma group (p = 0.006). The radius of curvature was larger in the early glaucoma group than in the other groups. Figure 1 shows the deformation amplitude according to glaucoma severity. The deflection amplitude did not differ between the normal control group (0.90 AE 0.01 mm) and the glaucoma group (0.90 AE 0.13 mm).
However, the deflection amplitude of the severe glaucoma group (0.92 AE 0.01 mm) was greater than the early glaucoma group (0.88 AE 0.01 mm, p = 0.031). The whole eye movement was not significantly different between the control group and the glaucoma group (p = 0.176).
The relationships between the CCT and deformation amplitude in the normal control group and the glaucoma group are shown in Fig. 2 . The relationship was significantly different between the normal control and glaucoma groups (p = 0.034, Fig. 2 ). The deformation amplitude showed a negative correlation with the CCT in the normal control group (r = À0.235), with a weaker negative relationship observed in the early glaucoma group (r = À0.099). However, in the moderate (r = 0.077) and severe (r = 0.340) glaucoma groups, the deformation amplitude showed a positive relationship with the CCT, showing an inverse relationship.
In a further analysis, the relationships between the CCT and the duration and number of antiglaucomatous eyedrops used were investigated. Both the duration and number of eyedrops used had negative correlations with the CCT (p = 0.010 and p = 0.001, respectively, Fig. 3 ).
Discussion
The aim of the present study was to examine and compare the biomechanical properties of non-glaucoma patients and glaucoma subgroups in vivo using the Corvis ST. The Corvis ST has been used in many previous studies to evaluate the biomechanical properties in patients with various corneal diseases, including keratoconus (Ali et al. 2014; Bak-Nielsen et al. 2014; Lanza et al. 2014; Tian et al. 2014a,b) , pseudoexfoliation (Ozkok et al. 2013; Yazgan et al. 2014 ) and glaucoma (Reznicek et al. 2013; Salvetat et al. 2014; Tejwani et al. 2014 ) as well as after various laser refractive surgeries (Hassan et al. 2014; Mastropasqua et al. 2014; Shen et al. 2014) . The results of any study are significant only if the parameters are reliable. Supporting the reliability of the Corvis ST, many studies have examined the accuracy and repeatability of the Corvis ST parameters in patients with various corneal conditions. Chen et al. (2014) reported that the IOP, CCT and deformation amplitude showed good repeatability in normal and post-PRK eyes. Similarly, Ali et al. (2014) reported highly repeatable IOP and CCT values and a fairly repeatable deformation amplitude in keratoconic eyes. Salvetat et al. (2014) reported an excellent ICC for the IOP, CCT, deformation amplitude and radius of curvature in normal control and glaucoma groups. In the current study, overall, glaucoma eyes were shown to have less deformable corneas and greater radius of corneal curvature than normal eyes after controlling for the IOP, CCT, age and axial length. In addition, the whole eye movement, which is the vertical displacement of the whole eye, was less in glaucomatous eyes compared to the normal eyes although this fell just short of statistical significance after adjusting for confounding factors. These results are consistent with those of previous studies. Tian et al. (2015) reported that
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Central corneal thickness eyes with glaucoma showed lower deformation amplitudes compared to IOP-and CCT-matched controls. Salvetat et al. (2014) also reported that primary open-angle glaucoma eyes showed less deformable corneas than age-matched controls with similar CCT. Previous studies performed using a different instrument, the ORA, have also shown differences in the corneal biomechanical properties between eyes with glaucoma and those of normal controls. Eyes with glaucoma showed decreased corneal hysteresis, indicating a reduced viscoelastic response compared with that in normal controls (Congdon et al. 2006; Mangouritsas et al. 2009 ).
In glaucoma, the tissue remodelling caused by exposure to an elevated IOP alters the biomechanical properties and results in increased stiffness of ocular structures (Quigley & Addicks 1981; Hernandez et al. 1990; Downs et al. 2005) . Quigley et al. (1991a,b) reported that there were changes in the extracellular connective tissues of the glaucomatous optic nerve head. Their studies showed alterations in the elastin molecules in the optic nerve head of glaucomatous eyes, which they suggested might alter the biomechanical properties of ocular tissues in glaucoma patients. Agoumi et al. (2011) reported the resistance of the lamina cribrosa to displacement in eyes with glaucoma compared with the eyes of age-matched non-glaucomatous controls. They suggested that the tissue remodelling associated with glaucomatous damage may result in increased stiffness and decreased compliance.
With regard to the relationship between CCT and the deformation amplitude, CCT showed a negative correlation with the deformation amplitude in the control group. However, this relationship was weak in the glaucoma group, emphasizing our finding that glaucomatous eyes exhibited a less deformable cornea independent of the CCT. Further, Mangouritsas et al. (2009) reported that the corneal biomechanical responses measured by ORA showed a strong correlation with the CCT in non-glaucoma patients; however, in glaucoma patients, the correlation was weaker. They suggested that diverse structural factors determine the differences in the biomechanical properties of glaucomatous versus nonglaucomatous corneas.
Regarding the deformation amplitude in the normal control group and glaucoma subgroups, the deformation amplitude was significantly greater in the severe glaucoma group than in the early glaucoma group. However, there was no significant difference between the normal control group and severe glaucoma group. There could be two possible reasons for this observation. First, the relationship between the deformation amplitude and CCT was different in the moderate and severe glaucoma groups compared with the normal controls and early glaucoma group. Usually, an increase in the CCT decreases the deformation amplitude (Ali et al. 2014; Valbon et al. 2014 ). However, a greater CCT was associated with a greater deformation amplitude in the moderate and severe glaucoma groups. This suggests that the corneal properties changed in the moderate and severe glaucoma groups, which led to a more deformable cornea. Second, the use of antiglaucomatous medications was more prominent in terms of the number and duration in the moderate and severe glaucoma groups compared with the early glaucoma group. In particular, the CCT was negatively correlated with the duration and number of antiglaucomatous eyedrops in the moderate and severe glaucoma groups compared with the early glaucoma group.
Furthermore, in our study, the deflection amplitude, which is the pure corneal component of the deformation amplitude, was greater in the severe glaucoma group compared to the early glaucoma group after adjusting for age, IOP, CCT and axial length, which may be related to the use of antiglaucomatous eyedrops.
The use of antiglaucomatous eyedrops has been shown to affect the corneal biomechanical properties in glaucomatous eyes. Similar to our present study, Wu et al. (2016) showed that glaucomatous eyes exposed to the long-term use of prostaglandin analogues showed significantly greater deformation amplitudes compared to na€ ıve glaucomatous eyes. They suggested that prostaglandin may influence corneal tissue remodelling by activating matrix metalloproteinases. Bolivar et al. (2015) also described the effects of prostaglandin analogues on corneal biomechanics. In their study, patients with glaucoma showed increased corneal hysteresis after 6 months of treatment with a prostaglandin analogue. Tsikripis et al. (2013) also showed an increase in corneal hysteresis, with increased viscoelastic properties, after topical treatment with prostaglandin analogues. They also suggested that the increased levels of matrix metalloproteinases and reduced levels of collagen resulting from the chronic use of a prostaglandin analogue were the mechanisms responsible for their results. Topical therapy with antiglaucoma medications, particularly prostaglandin analogues, decreased the CCT in patients with glaucoma (Viswanathan et al. 2013; You & Cho 2013) . Benzalkonium chloride has also been shown to affect the CCT in rabbits (Chen et al. 2011) . The use of antiglaucoma medication could therefore have affected the corneal biomechanical properties both directly and in conjunction with the thinning of the central cornea, which might explain the reverse response of the deformation amplitude in the moderate and severe glaucoma groups in our study. However, this is our speculation, and more studies are warranted to study the effects of antiglaucoma medications on the corneal biomechanics in various stages of glaucoma.
When considering the findings of other studies in relation to the negative relationship between the IOP and deformation amplitude, it may be concluded that the increasing deformation amplitude was caused by the decreased IOP in the severe glaucoma group (Ali et al. 2014) . However, the decreased IOP in the more advanced stages of glaucoma may be, in a large part, the effect of exposure to a greater number of antiglaucomatous medications or an underestimation of the IOP due to the thinner CCT, which may also be an effect of antiglaucomatous medications. Even after adjusting for the IOP, CCT, age and axial length, all of which may affect the deformation amplitude, the difference was still significant.
Our study has some limitations. First, repeated IOP measurements, the use of anaesthetic drops for Goldmann applanation tonometry or the corneal deformation after Corvis ST may have influenced subsequent IOP measurements. To minimize the influences of these factors, the order of IOP measurements was randomized, with at least 3 min between measurements and 30 min between measurements using different instruments. Second, specific types of antiglaucomatous medications, especially certain topical medication, which may have influenced the results based on their different effects on the corneal biomechanical properties, were not considered in the present study. Further studies are needed to assess the effects of different types of medications on the corneal deformability.
In conclusion, the glaucoma group showed less deformable corneas than did the normal control group after adjusting for the IOP, CCT, age and axial length. However, within the glaucoma group, the deformation amplitude was greater in the severe glaucoma group than in the early glaucoma group. In the eyes with moderate and severe glaucoma, the number and duration of antiglaucomatous eye drop treatments may have affected the CCT and biomechanical properties of the cornea. The combined effects of stiffening due to glaucoma and increased viscoelastic properties caused by the chronic use of antiglaucomatous eyedrops may have resulted in the present findings.
